Rabeprazole Sodium Tablet, Delayed Release
Product Images NDC 68788-7459

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Rabeprazole Sodium (NDC 68788-7459). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Preferred Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Rabeprazole Sodium Delayed Released Tablets 20mg (Rabe 30 Count)

This is a description of a medication called "Rabeprazole Sodium Delayed Release." It comes in tablets of 20mg and is the generic equivalent of a drug called "Aciphex." Each tablet contains 20mg of rabeprazole sodium. The medication is produced by Ascend Laboratories, LLC and caution is given that federal law prohibits its transfer to anyone it was not prescribed for. There is further information provided such as batch number, NDC (National Drug Code), and expiration date.*

FDA Label Image

Rabe-str (Rabe Str)

FDA Label Image

Rabe-str2 (Rabe Str2)

The provided text seems to be a graph showing the mean scores for Heartburn at different days of a study. The study seems to have three groups: Placebo, RAB 10mg, and RAB 20mg. The scores range from 0 to 5, where 0 indicates no heartburn, and 5 indicates very severe heartburn.*

FDA Label Image

Rabe-str3 (Rabe Str3)

The text provides a chart of mean scores for a study comparing a placebo group (n=58) to a group taking 20 mg of RAB (n=59) at different time points (14, 7, 0, -7, -14, -21, -28) of the study. The study measured heartburn scores, with a scale of 0 (none) to 5 (very severe).*

FDA Label Image

Rabe-str4 (Rabe Str4)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.